Alterity Therapeutics (ATHE) Operating Margin (2019)
Alterity Therapeutics (ATHE) posted quarterly Operating Margin of 304.03% for Q4 2019.
Alterity Therapeutics (ATHE) Operating Margin (2019) Analysis & Trends
Alterity Therapeutics' Operating Margin history runs 1 years deep, the most recent figure standing at 304.03% for Q4 2019.
- In Q4 2019, Operating Margin changed N/A year-over-year to 304.03%; the TTM figure through Dec 2019 stood at 633.99% (changed N/A YoY), while the FY2012 annual figure was 106.18%, up 378.0% from the prior year.
- Operating Margin for Q4 2019 stood at 304.03%.
- The five-year high for Operating Margin was 304.03% in Q4 2019, with the low at 304.03% in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.75% |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -304.03% |